Biopharmaceutics Aspects of Sugar Alcohols: Implementation of Patient-Centricity in Pharmaceutical Development and Clinical Use
Molecular Pharmaceutics · 07.04.2025 · 22 (4) · 1775-1789
DOI: 10.1021/acs.molpharmaceut.4c01309 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, online erschienen am 10.03.2025. Verfasst von Kazuki Matsui. Beteiligte Einrichtung: Biopharmaceutics Group, Pharmaceutical R&D, Ono Pharmaceutical Co., Ltd., 3-1-1, Sakurai, Shimamoto-cho, Mishima-gun, Osaka 618-8585, Japan. Hauptthemen laut MEDLINE: Sugar Alcohols, Biopharmaceutics, Drug Development. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 110 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biopharmaceutics Group, Pharmaceutical R&D, Ono Pharmaceutical Co., Ltd., 3-1-1, Sakurai, Shimamoto-cho, Mishima-gun, Osaka 618-8585, Japan.
ORCID-Profile: Kazuki Matsui
Zitieren
APA
Matsui, K. (2025). Biopharmaceutics Aspects of Sugar Alcohols: Implementation of Patient-Centricity in Pharmaceutical Development and Clinical Use. Molecular Pharmaceutics, 22(4), 1775-1789. https://doi.org/10.1021/acs.molpharmaceut.4c01309
Vancouver
Matsui K. Biopharmaceutics Aspects of Sugar Alcohols: Implementation of Patient-Centricity in Pharmaceutical Development and Clinical Use. Molecular Pharmaceutics. 2025;22(4):1775-1789. doi:10.1021/acs.molpharmaceut.4c01309
BibTeX
@article{Matsui2025,
author = {Matsui, Kazuki},
title = {Biopharmaceutics Aspects of Sugar Alcohols: Implementation of Patient-Centricity in Pharmaceutical Development and Clinical Use},
journal = {Molecular Pharmaceutics},
year = {2025},
volume = {22},
number = {4},
pages = {1775--1789},
doi = {10.1021/acs.molpharmaceut.4c01309}
}
EUVIMED